Key result
Clopidogrel monotherapy is safer than the combination of clopidogrel and aspirin for the secondary prevention of acute ischemic stroke.
Why the study?
Does aspirin and clopidogrel compared with clopidogrel alone improve secondary prevention of acute ischemic stroke in high-risk patients?
Does aspirin and clopidogrel compared with clopidogrel alone improve secondary prevention of acute ischemic stroke in high-risk patients?
Clopidogrel alone is safer than dual antiplatelet therapy with aspirin and clopidogrel for secondary prevention in high-risk patients with recent ischemic stroke or TIA.
Answers are grounded in this paper and cite their sources.
May favor clopidogrel monotherapy for secondary stroke prevention; leaves open confirmation in randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Woelke et al. (2017) studied this question. Clopidogrel monotherapy is safer than the combination of clopidogrel and aspirin for the secondary prevention of acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: